|Bid||121.00 x 800|
|Ask||124.17 x 1300|
|Day's range||120.59 - 122.89|
|52-week range||119.59 - 158.34|
|Beta (5Y monthly)||0.94|
|PE ratio (TTM)||17.71|
|Forward dividend & yield||2.84 (2.35%)|
|Ex-dividend date||05 Oct 2023|
|1y target est||N/A|
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors are optimistic about Quest Diagnostics (DGX), backed by collaborations with health plans and upbeat guidance.
Quest Diagnostics (DGX) and Americares will provide 10 clinics with no-cost diagnostic services for a year to help patients manage chronic disease.